首页 > 最新文献

Maedica最新文献

英文 中文
Occult Hepatitis B Infection among Blood Donors in Northwestern Greece. 希腊西北部献血者中的隐性乙型肝炎感染。
Pub Date : 2024-03-01 DOI: 10.26574/maedica.2024.19.1.17
Maria Leontari, Ioanna Mousavere, Fotios S Fousekis, Aikaterini Kalampoki, Gerasimos Baltayiannis

Background: Occult hepatitis B virus infection (OBI) is characterized by the presence of HBV DNA in individuals who test negative for hepatitis B surface antigen (HBsAg). It poses diagnostic challenges and contributes to chronic liver diseases. Understanding its epidemiology, pathogenesis and clinical outcomes remains essential. This study aimed to assess the prevalence and characteristics of OBI in Northwestern Greece. Methods:Serum samples were prospectively collected from 702 blood donors at the University Hospital of Ioannina, Greece, between February 2018 and September 2022. The investigation focused on the presence of hepatitis B virus (HBV) markers, utilizing the Abbott Architect HBsAg and HBcAb HB Qualitative II kit for the detection of HBsAg and anti-HBc, respectively. Further analysis was conducted on serum samples from individuals who tested negative for HBsAg but positive for anti-HBc, employing polymerase chain reaction (PCR) to detect HBV-DNA. In instances of OBI, sequencing and mutation analysis of the HBV pre-S/S gene were carried out for comprehensive characterization. Results:Screening revealed 56 cases (7.9%) with active HBV infection (HBsAg positive) and identified 144 cases (20.5%) indicative of past HBV infection (HBsAg negative, anti-HBc positive). Additionally, a prevalence of 5.4% (38/702) of OBI was detected. Among these, 36 cases exhibited a low HBV DNA load of less than 225 IU/mL. Notably, one OBI patient was co-infected with HIV. Furthermore, two cases of OBI with high HBV-DNA levels exceeding 200,000 IU/ml were detected. Sequencing analysis unveiled S- and pre-S mutations in four cases of OBI, including both instances with elevated HBV-DNA levels. Conclusion:In a region with a high proportion of immigrants from countries where HBV is endemic, a high prevalence of HBV infection and occult HBV infection (OBI) has been detected. Furthermore, mutations in the S gene were found to be associated with cases of OBI with high levels of HBV-DNA. However, additional research is needed to validate the results and understand the clinical relevance of specific OBI mutations for disease progression and treatment efficacy.

背景:隐匿性乙型肝炎病毒感染(OBI)的特征是乙型肝炎表面抗原(HBsAg)检测呈阴性的人体内存在 HBV DNA。隐匿性乙型肝炎病毒感染给诊断带来挑战,并导致慢性肝病。了解其流行病学、发病机制和临床结果仍然至关重要。本研究旨在评估 OBI 在希腊西北部的流行情况和特征。方法:2018 年 2 月至 2022 年 9 月期间,希腊约阿尼纳大学医院前瞻性地收集了 702 名献血者的血清样本。调查重点是乙型肝炎病毒(HBV)标记物的存在情况,采用雅培 Architect HBsAg 和 HBcAb HB Qualitative II 试剂盒分别检测 HBsAg 和抗 HBc。对于 HBsAg 检测阴性但抗-HBc 检测阳性者的血清样本,则采用聚合酶链反应 (PCR) 检测 HBV-DNA 进行进一步分析。对于 OBI 病例,则对 HBV 前 S/S 基因进行测序和突变分析,以全面确定其特征。结果:筛查结果显示,56 例(7.9%)患者为活动性 HBV 感染(HBsAg 阳性),144 例(20.5%)患者为既往 HBV 感染(HBsAg 阴性,抗 HBc 阳性)。此外,还发现了 5.4%(38/702)的 OBI 患病率。其中,36 例患者的 HBV DNA 负载低于 225 IU/mL。值得注意的是,一名 OBI 患者同时感染了 HIV。此外,有两例 OBI 患者的 HBV DNA 含量超过 200,000 IU/ml。测序分析揭示了四例 OBI 中的 S 型和前 S 型突变,包括两例 HBV-DNA 水平升高的病例。结论:在一个来自 HBV 流行国家的移民比例较高的地区,HBV 感染和隐性 HBV 感染(OBI)的发病率很高。此外,还发现 S 基因突变与高水平 HBV-DNA 的 OBI 病例有关。然而,还需要更多的研究来验证这些结果,并了解特定 OBI 基因突变与疾病进展和治疗效果的临床相关性。
{"title":"Occult Hepatitis B Infection among Blood Donors in Northwestern Greece.","authors":"Maria Leontari, Ioanna Mousavere, Fotios S Fousekis, Aikaterini Kalampoki, Gerasimos Baltayiannis","doi":"10.26574/maedica.2024.19.1.17","DOIUrl":"10.26574/maedica.2024.19.1.17","url":null,"abstract":"<p><p><b>Background:</b> Occult hepatitis B virus infection (OBI) is characterized by the presence of HBV DNA in individuals who test negative for hepatitis B surface antigen (HBsAg). It poses diagnostic challenges and contributes to chronic liver diseases. Understanding its epidemiology, pathogenesis and clinical outcomes remains essential. This study aimed to assess the prevalence and characteristics of OBI in Northwestern Greece. <b>Methods:</b>Serum samples were prospectively collected from 702 blood donors at the University Hospital of Ioannina, Greece, between February 2018 and September 2022. The investigation focused on the presence of hepatitis B virus (HBV) markers, utilizing the Abbott Architect HBsAg and HBcAb HB Qualitative II kit for the detection of HBsAg and anti-HBc, respectively. Further analysis was conducted on serum samples from individuals who tested negative for HBsAg but positive for anti-HBc, employing polymerase chain reaction (PCR) to detect HBV-DNA. In instances of OBI, sequencing and mutation analysis of the HBV pre-S/S gene were carried out for comprehensive characterization. <b>Results:</b>Screening revealed 56 cases (7.9%) with active HBV infection (HBsAg positive) and identified 144 cases (20.5%) indicative of past HBV infection (HBsAg negative, anti-HBc positive). Additionally, a prevalence of 5.4% (38/702) of OBI was detected. Among these, 36 cases exhibited a low HBV DNA load of less than 225 IU/mL. Notably, one OBI patient was co-infected with HIV. Furthermore, two cases of OBI with high HBV-DNA levels exceeding 200,000 IU/ml were detected. Sequencing analysis unveiled S- and pre-S mutations in four cases of OBI, including both instances with elevated HBV-DNA levels. <b>Conclusion:</b>In a region with a high proportion of immigrants from countries where HBV is endemic, a high prevalence of HBV infection and occult HBV infection (OBI) has been detected. Furthermore, mutations in the S gene were found to be associated with cases of OBI with high levels of HBV-DNA. However, additional research is needed to validate the results and understand the clinical relevance of specific OBI mutations for disease progression and treatment efficacy.</p>","PeriodicalId":74094,"journal":{"name":"Maedica","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11079725/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140913053","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Solitary Fibrous Tumor of the Masticator Space with Unusual Extension: a Case Report. 咀嚼肌间隙伴异常扩展的单发纤维性肿瘤:病例报告。
Pub Date : 2024-03-01 DOI: 10.26574/maedica.2024.19.1.154
Evangelos Giotakis, Athina Zarachi, Spyridoula Derka, Georgios Pavlidis, Aikaterini Lianou, Victoria Tsoumani, Angelos Liontos, Evangelos Tsiambas, Vasileios Ragos

Background: We present the case of a patient with solitary fibrous tumor of the masticator space with unusual extension. Case presentation: A 43-year-old woman presented with a painless mass with intraoral extension on the right cheek. The B-scan sonograph and magnetic resonance imaging revealed the extension of the tumor. The biopsy performed under local anesthesia raised the suspicion of a solitary fibrous tumor. Tumor excision included a preoperative tumor embolization. The surgical removal of the tumor included a partial parotidectomy on the right side, insertion of masseteric and temporalis muscle, resection of the middle part of the zygomatic bone and stabilization of the bone with a plate, mobilization of the tumor from the maxillary sinus and the pterygopalatine fossa through an endoscopic approach and an approach via partial resection of the anterior wall of the maxillary sinus after identifying and sparing the infraorbital nerve. Ôhe histological findings confirmed the diagnosis of solitary fibrous tumor. The patient's treatment completed with radiation therapy, and 2.5 years later, there was recurrence in the right temporal area. Conclusion:To our knowledge, this is the second reported case of solitary fibrous tumor arising in the masticator space and the only case with extension intraorally and in the paranasal sinuses. Tumor embolization and complete surgical excision are the most frequently recommended treatments.

背景:我们报告了一例咀嚼肌间隙单发纤维性肿瘤患者的病例,该肿瘤具有不寻常的扩展。病例介绍:一名 43 岁的女性患者因无疼痛感的肿块就诊,肿块口腔内延伸至右脸颊。B 扫描声像图和磁共振成像显示肿瘤有扩展。在局部麻醉下进行的活组织检查怀疑是单发纤维瘤。肿瘤切除术包括术前肿瘤栓塞。肿瘤切除手术包括右侧腮腺部分切除术,插入颚肌和颞肌,切除颧骨中部并用钢板固定骨头,通过内窥镜方法从上颌窦和翼腭窝移除肿瘤,并在识别和保留眶下神经后通过上颌窦前壁部分切除肿瘤。组织学结果确诊为单发纤维瘤。患者接受放射治疗后,2.5 年后右颞部肿瘤复发。结论:据我们所知,这是第二例报道的发生在咀嚼肌间隙的单发纤维瘤,也是唯一一例在口腔内和鼻旁窦扩展的病例。肿瘤栓塞和完全手术切除是最常用的治疗方法。
{"title":"Solitary Fibrous Tumor of the Masticator Space with Unusual Extension: a Case Report.","authors":"Evangelos Giotakis, Athina Zarachi, Spyridoula Derka, Georgios Pavlidis, Aikaterini Lianou, Victoria Tsoumani, Angelos Liontos, Evangelos Tsiambas, Vasileios Ragos","doi":"10.26574/maedica.2024.19.1.154","DOIUrl":"10.26574/maedica.2024.19.1.154","url":null,"abstract":"<p><p><b>Background:</b> We present the case of a patient with solitary fibrous tumor of the masticator space with unusual extension. <b>Case presentation:</b> A 43-year-old woman presented with a painless mass with intraoral extension on the right cheek. The B-scan sonograph and magnetic resonance imaging revealed the extension of the tumor. The biopsy performed under local anesthesia raised the suspicion of a solitary fibrous tumor. Tumor excision included a preoperative tumor embolization. The surgical removal of the tumor included a partial parotidectomy on the right side, insertion of masseteric and temporalis muscle, resection of the middle part of the zygomatic bone and stabilization of the bone with a plate, mobilization of the tumor from the maxillary sinus and the pterygopalatine fossa through an endoscopic approach and an approach via partial resection of the anterior wall of the maxillary sinus after identifying and sparing the infraorbital nerve. Ôhe histological findings confirmed the diagnosis of solitary fibrous tumor. The patient's treatment completed with radiation therapy, and 2.5 years later, there was recurrence in the right temporal area. <b>Conclusion:</b>To our knowledge, this is the second reported case of solitary fibrous tumor arising in the masticator space and the only case with extension intraorally and in the paranasal sinuses. Tumor embolization and complete surgical excision are the most frequently recommended treatments.</p>","PeriodicalId":74094,"journal":{"name":"Maedica","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11079748/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140913193","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Sylimarin Versus Essential Phospholipids in Metabolic Associated Steatotic Liver Disease (MASLD) - A Prospective Comparative Randomized Trial. 代谢相关性脂肪性肝病(MASLD)中西力马林与必需磷脂的前瞻性比较随机试验。
Pub Date : 2024-03-01 DOI: 10.26574/maedica.2024.19.1.9
Teodora Manuc, Carmen Monica Preda, Doina Istratescu, Liana Gheorghe, Razvan Cerban, Carmen Ester, Tudor Gheorghe Stroie, Raluca Ioana Alecu, Claudiu Mihai Ciuciureanu, Alexandra Ioana Marin, Letitia Tugui, Cristian Tieranu, Sorin Lucian Andrei, Mircea Diculescu, Mircea Manuc

Introduction:Metabolic dysfunction-associated steatotic liver disease (MASLD) is an entity with a growing incidence but only a few pharmacological options. In Romania, the prevalence of MASLD has been increasing, while that of viral hepatitis has been decreasing. The purpose of this study is to compare two supplements for the treatment of MASLD. Methods:Between January 2020 and May 2022, 90 patients with MASLD were randomized to receive either silymarin 150 mg b.i.d (45 subjects) or essential phospholipids (EPLs) 825 mg b.i.d. (45 subjects) for six months. All study participants received recommendations for lifestyle and diet modifications. Assessment of the severity of steatosis and liver fibrosis was performed using FibroScan® with controlled attenuated parameter (CAP) at the beginning and end of treatment. Results:A total of 68 patients completed the trial. The two groups were statistically comparable in terms of clinical, biological and FibroScanR parameters. Aspartate transferase (AST) decreased from a median of 40 to 28 IU/L in the EPL arm (compared to 25→¨25.5 IU/L in the silymarin arm) (p-value=0.11) and alanine transaminase (ALT) decreased from 46 to 37.5 IU/L (compared to 31→30 IU/L) (p-value = 0.38). Plasma cholesterol levels also decreased significantly in the EPL group (218→189.5 mg/dL) compared to the silymarin arm (217→209 mg/dL) (p = 0.01). At the end of treatment, liver stiffness decreased by 0.7 KPa (6.9→6.2 KPa) in the EPL group but increased by 2.3 KPa (7.2→9.5 KPa) in the silymarin group (p = 0.1). The reduction in hepatic steatosis was comparable between the two groups: it decreased by 5% of the initial value. Conclusion:In our study, a six-month treatment with EPLs was superior to silymarin in MASLD patients because it succeeded in improving both laboratory parameters and liver fibrosis, as estimated by FibroScan®.

导言:代谢功能障碍相关性脂肪性肝病(MASLD)的发病率越来越高,但只有少数几种药物可供选择。在罗马尼亚,代谢功能障碍相关性脂肪性肝病的发病率一直在上升,而病毒性肝炎的发病率却在下降。本研究旨在比较治疗 MASLD 的两种补充剂。方法:2020 年 1 月至 2022 年 5 月期间,90 名 MASLD 患者被随机分配到水飞蓟素 150 毫克/日(45 人)或必需磷脂(EPLs)825 毫克/日(45 人)中,接受为期 6 个月的治疗。所有研究参与者都接受了改变生活方式和饮食的建议。在治疗开始和结束时,使用带受控衰减参数 (CAP) 的 FibroScan® 对脂肪变性和肝纤维化的严重程度进行评估。结果:共有 68 名患者完成了试验。两组患者的临床、生物和 FibroScanR 参数在统计学上具有可比性。EPL 组的天冬氨酸转氨酶(AST)从中位数 40 IU/L 降至 28 IU/L(而水飞蓟素组为 25→¨25.5 IU/L)(p 值=0.11),丙氨酸转氨酶(ALT)从 46 IU/L 降至 37.5 IU/L(而水飞蓟素组为 31→30 IU/L)(p 值=0.38)。EPL 组的血浆胆固醇水平(218→189.5 mg/dL)也明显低于水飞蓟素组(217→209 mg/dL)(p = 0.01)。治疗结束时,EPL 组的肝硬度降低了 0.7 KPa(6.9→6.2 KPa),而水飞蓟素组的肝硬度增加了 2.3 KPa(7.2→9.5 KPa)(p = 0.1)。两组的肝脏脂肪变性程度相当:均比初始值降低了 5%。结论:在我们的研究中,用 EPLs 对 MASLD 患者进行为期 6 个月的治疗优于水飞蓟素,因为它成功地改善了实验室参数和肝纤维化(通过 FibroScan® 评估)。
{"title":"Sylimarin <i>Versus</i> Essential Phospholipids in Metabolic Associated Steatotic Liver Disease (MASLD) - A Prospective Comparative Randomized Trial.","authors":"Teodora Manuc, Carmen Monica Preda, Doina Istratescu, Liana Gheorghe, Razvan Cerban, Carmen Ester, Tudor Gheorghe Stroie, Raluca Ioana Alecu, Claudiu Mihai Ciuciureanu, Alexandra Ioana Marin, Letitia Tugui, Cristian Tieranu, Sorin Lucian Andrei, Mircea Diculescu, Mircea Manuc","doi":"10.26574/maedica.2024.19.1.9","DOIUrl":"10.26574/maedica.2024.19.1.9","url":null,"abstract":"<p><p><b>Introduction:</b>Metabolic dysfunction-associated steatotic liver disease (MASLD) is an entity with a growing incidence but only a few pharmacological options. In Romania, the prevalence of MASLD has been increasing, while that of viral hepatitis has been decreasing. The purpose of this study is to compare two supplements for the treatment of MASLD. <b>Methods:</b>Between January 2020 and May 2022, 90 patients with MASLD were randomized to receive either silymarin 150 mg b.i.d (45 subjects) or essential phospholipids (EPLs) 825 mg b.i.d. (45 subjects) for six months. All study participants received recommendations for lifestyle and diet modifications. Assessment of the severity of steatosis and liver fibrosis was performed using FibroScan® with controlled attenuated parameter (CAP) at the beginning and end of treatment. <b>Results:</b>A total of 68 patients completed the trial. The two groups were statistically comparable in terms of clinical, biological and FibroScanR parameters. Aspartate transferase (AST) decreased from a median of 40 to 28 IU/L in the EPL arm (compared to 25→¨25.5 IU/L in the silymarin arm) (p-value=0.11) and alanine transaminase (ALT) decreased from 46 to 37.5 IU/L (compared to 31→30 IU/L) (p-value = 0.38). Plasma cholesterol levels also decreased significantly in the EPL group (218→189.5 mg/dL) compared to the silymarin arm (217→209 mg/dL) (p = 0.01). At the end of treatment, liver stiffness decreased by 0.7 KPa (6.9→6.2 KPa) in the EPL group but increased by 2.3 KPa (7.2→9.5 KPa) in the silymarin group (p = 0.1). The reduction in hepatic steatosis was comparable between the two groups: it decreased by 5% of the initial value. <b>Conclusion:</b>In our study, a six-month treatment with EPLs was superior to silymarin in MASLD patients because it succeeded in improving both laboratory parameters and liver fibrosis, as estimated by FibroScan®.</p>","PeriodicalId":74094,"journal":{"name":"Maedica","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11079726/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140913388","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Pyogenic Granuloma Gravidarum of the Nasal Cavity Causing Recurrent Epistaxis. A Case Report and Review of the Literature. 鼻腔妊娠化脓性肉芽肿导致复发性鼻衄。病例报告与文献综述。
Pub Date : 2024-03-01 DOI: 10.26574/maedica.2024.19.1.160
Lentiona Basiari, Ioannis Komnos, Eleni Litsou, Maria Michali, Panagiotis Oikonomou, Georgios Psychogios

Pyogenic granuloma is a benign proliferative fibrovascular lesion commonly arising from the skin and mucous membranes of the head and neck region. Histologically, this tumor is characterized by vascular proliferation and a circumscribed group of capillaries organized in lobules. It is usually located in the oral cavity and nasal location is less frequent. When it occurs in pregnant women, it is usually referred as pyogenic granuloma gravidarum. In this article we present the case of a pyogenic granuloma gravidarum in a young woman with intermittent epistaxis during the last trimester of pregnancy that did not resolve after childbirth and was treated with transnasal endoscopic resection and cautery at the base of the lesion for hemostasis under local anesthesia.

化脓性肉芽肿是一种良性增生性纤维血管性病变,常见于头颈部皮肤和粘膜。从组织学上看,这种肿瘤的特点是血管增生和周缘的毛细血管群呈小叶状。它通常位于口腔,鼻腔较少见。当它发生在孕妇身上时,通常被称为妊娠化脓性肉芽肿。本文介绍了一例妊娠化脓性肉芽肿病例,患者为一名年轻女性,在妊娠最后三个月出现间歇性鼻衄,分娩后鼻衄仍未缓解,在局麻下采用经鼻内镜切除术和病灶底部烧灼止血治疗。
{"title":"Pyogenic Granuloma Gravidarum of the Nasal Cavity Causing Recurrent Epistaxis. A Case Report and Review of the Literature.","authors":"Lentiona Basiari, Ioannis Komnos, Eleni Litsou, Maria Michali, Panagiotis Oikonomou, Georgios Psychogios","doi":"10.26574/maedica.2024.19.1.160","DOIUrl":"10.26574/maedica.2024.19.1.160","url":null,"abstract":"<p><p>Pyogenic granuloma is a benign proliferative fibrovascular lesion commonly arising from the skin and mucous membranes of the head and neck region. Histologically, this tumor is characterized by vascular proliferation and a circumscribed group of capillaries organized in lobules. It is usually located in the oral cavity and nasal location is less frequent. When it occurs in pregnant women, it is usually referred as pyogenic granuloma gravidarum. In this article we present the case of a pyogenic granuloma gravidarum in a young woman with intermittent epistaxis during the last trimester of pregnancy that did not resolve after childbirth and was treated with transnasal endoscopic resection and cautery at the base of the lesion for hemostasis under local anesthesia.</p>","PeriodicalId":74094,"journal":{"name":"Maedica","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11079736/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140913056","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Case Report on Botulinum Toxin Treatment for Complex Regional Pain Syndrome in a Digit Reconstruction. 肉毒杆菌毒素治疗复发性区域疼痛综合征的病例报告。
Pub Date : 2024-03-01 DOI: 10.26574/maedica.2024.19.1.182
R Rashaan, P T Arkoumanis, C Gakis, F A Lyssiotis, J Michalis, P Anagnostopoulos, K Stratakis

Objective:To evaluate subcutaneous Botulinum toxin type A (BTX-A) efficacy in alleviating severe allodynia in complex regional pain syndrome (CRPS) type II post-digit reconstruction. Methods: After surgical debridement and flap reconstruction for post-traumatic necrosis, a CRPS type II patient received subcutaneous BTX-A. Assessments tracked symptom changes and daily life improvements. Discussion:There are various CRPS management modalities, including rehabilitation and pharmacology. The limited efficacy of conventional non-steroidal antiinflammatory drugs contrasts with promising subcutaneous BTX-A, offering rapid pain relief. Conclusion:Our case underscores the efficacy of subcutaneous BTX-A in CRPS type II, prompting further research and safe outpatient protocol development.

目的:评估皮下注射A型肉毒杆菌毒素(BTX-A)对缓解复杂性区域疼痛综合征(CRPS)II型趾骨重建术后严重异感症的疗效。治疗方法一名 II 型 CRPS 患者在因创伤后坏死而进行手术清创和皮瓣重建后,接受了皮下 BTX-A。评估跟踪了症状变化和日常生活改善情况。讨论:CRPS的治疗方法多种多样,包括康复治疗和药物治疗。传统的非甾体抗炎药物疗效有限,而皮下注射BTX-A可迅速缓解疼痛,两者形成鲜明对比。结论:我们的病例强调了皮下BTX-A对CRPS II型的疗效,促使我们进一步开展研究并制定安全的门诊方案。
{"title":"Case Report on Botulinum Toxin Treatment for Complex Regional Pain Syndrome in a Digit Reconstruction.","authors":"R Rashaan, P T Arkoumanis, C Gakis, F A Lyssiotis, J Michalis, P Anagnostopoulos, K Stratakis","doi":"10.26574/maedica.2024.19.1.182","DOIUrl":"10.26574/maedica.2024.19.1.182","url":null,"abstract":"<p><p><b>Objective:</b>To evaluate subcutaneous Botulinum toxin type A (BTX-A) efficacy in alleviating severe allodynia in complex regional pain syndrome (CRPS) type II post-digit reconstruction. <b>Methods:</b> After surgical debridement and flap reconstruction for post-traumatic necrosis, a CRPS type II patient received subcutaneous BTX-A. Assessments tracked symptom changes and daily life improvements. <b>Discussion:</b>There are various CRPS management modalities, including rehabilitation and pharmacology. The limited efficacy of conventional non-steroidal antiinflammatory drugs contrasts with promising subcutaneous BTX-A, offering rapid pain relief. <b>Conclusion:</b>Our case underscores the efficacy of subcutaneous BTX-A in CRPS type II, prompting further research and safe outpatient protocol development.</p>","PeriodicalId":74094,"journal":{"name":"Maedica","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11079730/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140913121","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Reasons for Repeated General Anesthesia for Dental Treatments of Uncooperative Children. 对不合作的儿童进行牙科治疗时重复全身麻醉的原因。
Pub Date : 2024-03-01 DOI: 10.26574/maedica.2024.19.1.66
Ali Vafaei, Sharareh Alagheband, Yalda Ahmadinia, Seyyede Shabnam Sajjadi, Naimeh Teimoory, Sepideh Fattahi, Amir Reza Jamei Khosroshahi

Objectives: In some cases, dental treatment of children under general anesthesia (GA) should be repeated due to treatment failures. This study evaluated the reasons leading to dental retreatment under GA in children under 12 years of age. Materials and methods:In this retrospective study, the records of all children who underwent dental treatment under GA between 2011-2021 in Tabriz Dental Faculty Hospital, Iran, were collected. The records of children treated under GA for the second time or more were analyzed. Collected data included age at first treatment, mental and/or physical disabilities, type of treatments and participation in follow-up sessions. Data were analyzed using Stata SE version 17. Results:In a group of 667 children who underwent general anesthesia for the first time (GA1), 41% (95% confidence interval [CI] 37.2%-44.9%) required retreatment. Among all age groups, 1-3-year-old children were more likely to require a second GA (GA2) compared to other age groups (all P < 0.05). Children with physical and mental disabilities were around eight times more likely to require a second GA (P < 0.05). Conclusion:Younger age, mental and physical disabilities, no or irregular participation in follow-up sessions and treatments such as composite resin restorations or pulpotomy were factors influencing repeated dental treatments under general anesthesia.

目的:在某些情况下,在全身麻醉(GA)下对儿童进行牙科治疗会因治疗失败而需要重新进行。本研究评估了导致 12 岁以下儿童在全身麻醉下接受牙科治疗的原因。材料和方法:在这项回顾性研究中,收集了伊朗大不里士牙科医学院附属医院在 2011-2021 年期间所有在 GA 下接受牙科治疗的儿童的记录。对第二次或第二次以上接受GA治疗的儿童记录进行了分析。收集的数据包括首次治疗时的年龄、精神和/或身体残疾情况、治疗类型以及是否参加随访。数据使用Stata SE 17版进行分析。结果:在首次接受全身麻醉(GA1)的667名儿童中,有41%(95%置信区间[CI] 37.2%-44.9%)需要再次治疗。在所有年龄组中,与其他年龄组相比,1-3 岁的儿童更有可能需要第二次全身麻醉(GA2)(所有 P 均小于 0.05)。有身体和精神残疾的儿童需要第二次GA的几率大约是其他年龄组的八倍(P < 0.05)。结论:年龄较小、精神和身体残疾、不参加或不定期参加复诊以及复合树脂修复或牙髓切断术等治疗是影响在全身麻醉下重复牙科治疗的因素。
{"title":"Reasons for Repeated General Anesthesia for Dental Treatments of Uncooperative Children.","authors":"Ali Vafaei, Sharareh Alagheband, Yalda Ahmadinia, Seyyede Shabnam Sajjadi, Naimeh Teimoory, Sepideh Fattahi, Amir Reza Jamei Khosroshahi","doi":"10.26574/maedica.2024.19.1.66","DOIUrl":"10.26574/maedica.2024.19.1.66","url":null,"abstract":"<p><p><b>Objectives:</b> In some cases, dental treatment of children under general anesthesia (GA) should be repeated due to treatment failures. This study evaluated the reasons leading to dental retreatment under GA in children under 12 years of age. <b>Materials and methods:</b>In this retrospective study, the records of all children who underwent dental treatment under GA between 2011-2021 in Tabriz Dental Faculty Hospital, Iran, were collected. The records of children treated under GA for the second time or more were analyzed. Collected data included age at first treatment, mental and/or physical disabilities, type of treatments and participation in follow-up sessions. Data were analyzed using Stata SE version 17. <b>Results:</b>In a group of 667 children who underwent general anesthesia for the first time (GA1), 41% (95% confidence interval [CI] 37.2%-44.9%) required retreatment. Among all age groups, 1-3-year-old children were more likely to require a second GA (GA2) compared to other age groups (all P < 0.05). Children with physical and mental disabilities were around eight times more likely to require a second GA (P < 0.05). <b>Conclusion:</b>Younger age, mental and physical disabilities, no or irregular participation in follow-up sessions and treatments such as composite resin restorations or pulpotomy were factors influencing repeated dental treatments under general anesthesia.</p>","PeriodicalId":74094,"journal":{"name":"Maedica","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11079742/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140913215","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Surgical Excision of a Laimer's Diverticulum: A Case Report and Review of the Literature. 手术切除莱默氏憩室:病例报告和文献综述。
Pub Date : 2024-03-01 DOI: 10.26574/maedica.2024.19.1.165
Alexios Tsikopoulos, Ioannis Pachiadakis, Petros Karkos, Emmanouil Zacharakis

A pharyngoesophageal diverticulum (PED) is a rare clinical entity. This paper reports on a 79-year-old male patient with PED and symptoms of dysphagia, regurgitation and chronic cough. The diverticulum was located on the dorsal side of the cervical esophagus, midline, inferior to the cricopharyngeal muscle. These findings were consistent with Laimer's diverticulum (LD), the rarest type of PED. This case proposes a surgical treatment of LD via an external transcervical approach.

咽食管憩室(PED)是一种罕见的临床病症。本文报告了一名 79 岁的男性患者,他患有 PED,并伴有吞咽困难、反胃和慢性咳嗽症状。憩室位于颈食管背侧、中线、环咽肌下部。这些发现与最罕见的 PED 类型莱默氏憩室(LD)一致。本病例提出了通过经颈部外入路手术治疗 LD 的方法。
{"title":"Surgical Excision of a Laimer's Diverticulum: A Case Report and Review of the Literature.","authors":"Alexios Tsikopoulos, Ioannis Pachiadakis, Petros Karkos, Emmanouil Zacharakis","doi":"10.26574/maedica.2024.19.1.165","DOIUrl":"10.26574/maedica.2024.19.1.165","url":null,"abstract":"<p><p>A pharyngoesophageal diverticulum (PED) is a rare clinical entity. This paper reports on a 79-year-old male patient with PED and symptoms of dysphagia, regurgitation and chronic cough. The diverticulum was located on the dorsal side of the cervical esophagus, midline, inferior to the cricopharyngeal muscle. These findings were consistent with Laimer's diverticulum (LD), the rarest type of PED. This case proposes a surgical treatment of LD via an external transcervical approach.</p>","PeriodicalId":74094,"journal":{"name":"Maedica","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11079752/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140913383","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Is There any Association between Vitamin D Deficiency and Recurrent Tonsillopharyngitis? An Updated Systematic Review. 维生素 D 缺乏与复发性扁桃体咽炎有关联吗?最新系统综述。
Pub Date : 2024-03-01 DOI: 10.26574/maedica.2021.19.1.116
Alexios Tsikopoulos, Konstantinos Tsikopoulos, Athanasios Fountarlis, Agathoklis Efthymiadis, Charalampos Festas, Konstantinos Garefis

Introduction: It has been theorized that vitamin D deficiency is directly associated with the occurrence of recurrent tonsillopharyngitis. The purpose of this study was to investigate the potential association between vitamin D levels and recurrent tonsillopharyngitis. Methods:We searched the databases of PubMed, Scopus and Cochrane Central Register of Controlled Trials (CENTRAL) until the 15th of August 2023. Original articles of any study design assessing the correlation between recurrent tonsillopharyngitis and vitamin D levels in both pediatric and adult patients were considered. Serum 25-hydroxyvitamin D level was the measured outcome. Quality assessment was carried out by using the Newcastle-Ottawa scale (NOS) for observational studies. Results:Eleven observational studies with a total of 2 503 participants were included in this systematic review. The qualitative synthesis revealed a possible association between recurrent tonsillopharyngitis and vitamin D deficiency. All studies, except one study, demonstrated a statistically significant association between the two conditions. As per our quality appraisal, all papers were deemed to be of moderate or good quality. Conclusion:This study shows a potential association between vitamin D deficiency and the development of recurrent tonsillopharyngitis. Future studies should not only investigate this association in a more comprehensive manner but also assess the prevention potential of vitamin D supplementation on tonsillopharyngitis pathogenesis.

导言有理论认为,维生素 D 缺乏与扁桃体咽炎反复发作直接相关。本研究旨在探讨维生素 D 水平与复发性扁桃体咽炎之间的潜在关联。方法:我们检索了 PubMed、Scopus 和 Cochrane Central Register of Controlled Trials (CENTRAL) 等数据库,直至 2023 年 8 月 15 日。研究对象包括评估儿童和成人患者复发性扁桃体咽炎与维生素 D 水平之间相关性的任何研究设计的原创文章。血清 25- 羟维生素 D 水平是测量结果。对观察性研究采用纽卡斯尔-渥太华量表(NOS)进行质量评估。结果:本系统综述纳入了 11 项观察性研究,共有 2 503 人参与。定性综述显示,复发性扁桃体咽炎与维生素 D 缺乏之间可能存在关联。除一项研究外,其他所有研究均显示这两种疾病之间存在统计学意义上的显著关联。根据我们的质量评估,所有论文的质量均为中等或良好。结论:本研究表明,维生素 D 缺乏与扁桃体咽炎复发之间存在潜在联系。今后的研究不仅应更全面地调查这种关联,还应评估补充维生素 D 对扁桃体咽炎发病机制的预防潜力。
{"title":"Is There any Association between Vitamin D Deficiency and Recurrent Tonsillopharyngitis? An Updated Systematic Review.","authors":"Alexios Tsikopoulos, Konstantinos Tsikopoulos, Athanasios Fountarlis, Agathoklis Efthymiadis, Charalampos Festas, Konstantinos Garefis","doi":"10.26574/maedica.2021.19.1.116","DOIUrl":"10.26574/maedica.2021.19.1.116","url":null,"abstract":"<p><p><b>Introduction:</b> It has been theorized that vitamin D deficiency is directly associated with the occurrence of recurrent tonsillopharyngitis. The purpose of this study was to investigate the potential association between vitamin D levels and recurrent tonsillopharyngitis. <b>Methods:</b>We searched the databases of PubMed, Scopus and Cochrane Central Register of Controlled Trials (CENTRAL) until the 15th of August 2023. Original articles of any study design assessing the correlation between recurrent tonsillopharyngitis and vitamin D levels in both pediatric and adult patients were considered. Serum 25-hydroxyvitamin D level was the measured outcome. Quality assessment was carried out by using the Newcastle-Ottawa scale (NOS) for observational studies. <b>Results:</b>Eleven observational studies with a total of 2 503 participants were included in this systematic review. The qualitative synthesis revealed a possible association between recurrent tonsillopharyngitis and vitamin D deficiency. All studies, except one study, demonstrated a statistically significant association between the two conditions. As <i>per</i> our quality appraisal, all papers were deemed to be of moderate or good quality. <b>Conclusion:</b>This study shows a potential association between vitamin D deficiency and the development of recurrent tonsillopharyngitis. Future studies should not only investigate this association in a more comprehensive manner but also assess the prevention potential of vitamin D supplementation on tonsillopharyngitis pathogenesis.</p>","PeriodicalId":74094,"journal":{"name":"Maedica","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11079729/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140913047","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Breastfeeding and its Association with Breast Cancer: a Systematic Review of the Literature. 母乳喂养及其与乳腺癌的关系:系统性文献综述。
Pub Date : 2024-03-01 DOI: 10.26574/maedica.2021.19.1.106
Georgia Oikonomou, Anastasia Bothou, Orovou Eirini, Maria Daglas, Maria Iliadou, Evangelia Antoniou, Ermioni Palaska

Objective:Breast cancer is a global public health issue. The disease can be diagnosed in both older and younger women, with the latter facing several dilemmas. Breastfeeding is of general concern to the scientific community as well as its connection with the prevention of breast cancer is being sought. The purpose of this review is to search for studies investigating the relationship between breast cancer and breastfeeding. Material and methods: The articles included in the present paper were searched in PubMed and Scopus databases according to PRISMA guidelines for systematic reviews. This systematic review sought primary studies investigating the relationship between breastfeeding and breast cancer and that were published in English between 2017-2022. Results:Seventeen articles that investigated the relationship of breast cancer with lactation duration, women's age, family history and lifestyle were included in the present review. Conclusion:It was found that, in most studies, breastfeeding could be evaluated as a protective factor of the disease. From all studied articles, the need for the design of additional studies investigating the relationship between breastfeeding and breast cancer emerges.

目的:乳腺癌是一个全球性的公共卫生问题。老年妇女和年轻妇女都可能被诊断出患有乳腺癌,后者面临着一些困境。母乳喂养受到科学界的普遍关注,母乳喂养与预防乳腺癌的关系也受到关注。本综述的目的是寻找调查乳腺癌与母乳喂养之间关系的研究。材料和方法:根据系统性综述的 PRISMA 准则,在 PubMed 和 Scopus 数据库中检索了本文收录的文章。本系统综述旨在寻找调查母乳喂养与乳腺癌之间关系的主要研究,这些研究在 2017-2022 年间以英文发表。结果:本综述共纳入17篇文章,这些文章调查了乳腺癌与哺乳期长短、女性年龄、家族史和生活方式之间的关系。结论:研究发现,在大多数研究中,母乳喂养可被评估为该疾病的保护因素。从所有研究文章来看,有必要设计更多的研究来调查母乳喂养与乳腺癌之间的关系。
{"title":"Breastfeeding and its Association with Breast Cancer: a Systematic Review of the Literature.","authors":"Georgia Oikonomou, Anastasia Bothou, Orovou Eirini, Maria Daglas, Maria Iliadou, Evangelia Antoniou, Ermioni Palaska","doi":"10.26574/maedica.2021.19.1.106","DOIUrl":"10.26574/maedica.2021.19.1.106","url":null,"abstract":"<p><p><b>Objective:</b>Breast cancer is a global public health issue. The disease can be diagnosed in both older and younger women, with the latter facing several dilemmas. Breastfeeding is of general concern to the scientific community as well as its connection with the prevention of breast cancer is being sought. The purpose of this review is to search for studies investigating the relationship between breast cancer and breastfeeding. <b>Material and methods:</b> The articles included in the present paper were searched in PubMed and Scopus databases according to PRISMA guidelines for systematic reviews. This systematic review sought primary studies investigating the relationship between breastfeeding and breast cancer and that were published in English between 2017-2022. <b>Results:</b>Seventeen articles that investigated the relationship of breast cancer with lactation duration, women's age, family history and lifestyle were included in the present review. <b>Conclusion:</b>It was found that, in most studies, breastfeeding could be evaluated as a protective factor of the disease. From all studied articles, the need for the design of additional studies investigating the relationship between breastfeeding and breast cancer emerges.</p>","PeriodicalId":74094,"journal":{"name":"Maedica","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11079727/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140913120","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Management of an Atypical Lipomatous Tumor/Well-Differentiated Liposarcoma of the Left Laterocervical Region: Report of a Rare Case. 左侧后颈部非典型脂肪瘤/好发性脂肪肉瘤的治疗:罕见病例报告
Pub Date : 2024-03-01 DOI: 10.26574/maedica.2024.19.1.191
Ioannis Komnos, Maria Michali, Lentiona Basiari, Georgios Tsirves, Georgios Psychogios

Liposarcomas are among the most usual cancerous growths of mesenchymal tissues and represent about 1% of head and neck sarcomas. They are extremely rare in childhood and are mostly seen between 30 and 60 years of age. The biologic behavior and histologic features of liposarcomas vary. Although these tumors grow very slowly and have a benign behavior, sometimes they grow rapidly and metastasize early, with fatal results. This case report presents a 63-year-old man with a tumor of the left side of the cervical region which has grown to a large size over four years. For an accurate diagnosis, fine needle aspiration biopsy (FNA) biopsy was performed. The cytological examination showed an adipose tumor. Surgical removal was done under local anesthesia and the pathologic examination showed a well-differentiated liposarcoma. These are usually early stage tumors, with fewer metastases than other sarcomas. Surgical abscission is the gold standard for the treatment of liposarcomas. The efficacy of postoperative radiotherapy or/and chemotherapy is controversial.

脂肪肉瘤是间质组织中最常见的肿瘤之一,约占头颈部肉瘤的 1%。脂肪肉瘤在儿童时期极为罕见,多见于 30 至 60 岁之间。脂肪肉瘤的生物学行为和组织学特征各不相同。虽然这些肿瘤生长非常缓慢且为良性,但有时也会生长迅速并发生早期转移,从而导致致命后果。本病例报告的患者是一名 63 岁的男性,其左侧颈部肿瘤在 4 年时间里逐渐增大。为了准确诊断,患者接受了细针穿刺活检(FNA)。细胞学检查显示为脂肪瘤。在局部麻醉下进行了手术切除,病理检查显示这是一种分化良好的脂肪肉瘤。这种肿瘤通常是早期肿瘤,转移率低于其他肉瘤。手术切除是治疗脂肪肉瘤的金标准。术后放疗或/和化疗的疗效尚存争议。
{"title":"Management of an Atypical Lipomatous Tumor/Well-Differentiated Liposarcoma of the Left Laterocervical Region: Report of a Rare Case.","authors":"Ioannis Komnos, Maria Michali, Lentiona Basiari, Georgios Tsirves, Georgios Psychogios","doi":"10.26574/maedica.2024.19.1.191","DOIUrl":"10.26574/maedica.2024.19.1.191","url":null,"abstract":"<p><p>Liposarcomas are among the most usual cancerous growths of mesenchymal tissues and represent about 1% of head and neck sarcomas. They are extremely rare in childhood and are mostly seen between 30 and 60 years of age. The biologic behavior and histologic features of liposarcomas vary. Although these tumors grow very slowly and have a benign behavior, sometimes they grow rapidly and metastasize early, with fatal results. This case report presents a 63-year-old man with a tumor of the left side of the cervical region which has grown to a large size over four years. For an accurate diagnosis, fine needle aspiration biopsy (FNA) biopsy was performed. The cytological examination showed an adipose tumor. Surgical removal was done under local anesthesia and the pathologic examination showed a well-differentiated liposarcoma. These are usually early stage tumors, with fewer metastases than other sarcomas. Surgical abscission is the gold standard for the treatment of liposarcomas. The efficacy of postoperative radiotherapy or/and chemotherapy is controversial.</p>","PeriodicalId":74094,"journal":{"name":"Maedica","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11079751/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140913050","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Maedica
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1